Publicacións en colaboración con investigadores/as de University of Cologne (4)

2017

  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977

  2. Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 5, pp. 689-697

2013

  1. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492

  2. Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: A cumulative analysis of up to 4.6 years of exposure

    Journal of Rheumatology, Vol. 40, Núm. 6, pp. 768-780